Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 12 Dec 2024

Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy

in Cancer Immunity and Immunotherapy

Teng Zhang
Wengang Li
Qian Chen
Weiping He
Jing Sun
Dong Li
Quan Wang
Xuezhang Duan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1508028

821 views

Original Research

Published on 12 Dec 2024

Bibliometric analysis and visualization of the research on the relationship between RNA methylation and immune cell infiltration in tumors

in Cancer Immunity and Immunotherapy

Sibo Meng
Guanghui Yang
Enhao Yu
Jiaxin Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477828

1,024 views

Original Research

Published on 11 Dec 2024

Cytokine screening identifies TNF to potentially enhance immunogenicity of pediatric sarcomas

in Cancer Immunity and Immunotherapy

Hendrik Gassmann
Melanie Thiede
Jennifer Weiß
Emilie Biele
Luisa Flohé
Helena Lachermaier
Carolin Prexler
Valentina Evdokimova
Laszlo Radvanyi
Irfan Akhtar

Frontiers in Immunology

doi 10.3389/fimmu.2024.1347404

1,252 views

Review

Published on 11 Dec 2024

Advances in biomarkers for immunotherapy in small-cell lung cancer

in Cancer Immunity and Immunotherapy

Hui Li
Peiyan Zhao
Lin Tian
Yuanhua Lu
Xinyue Wang
Wenjun Shao
Ying Cheng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490590

1,348 views

Original Research

Published on 11 Dec 2024

Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses

in Cancer Immunity and Immunotherapy

Zhibing Liu
Lei Han
Xiaoyu Ji
Xiaole Wang
Jinbo Jian
Yujie Zhai
Yingjiang Xu
Feng Wang
Xiuwen Wang
Fangling Ning

Frontiers in Immunology

doi 10.3389/fimmu.2024.1486652

1,329 views

Original Research

Published on 11 Dec 2024

SOX13 as a potential prognostic biomarker linked to immune infiltration and ferroptosis inhibits the proliferation, migration, and metastasis of thyroid cancer cells

in Cancer Immunity and Immunotherapy

Yan-yan Ma
Wei-ye Zhou
Yue Qian
Ying-ying Mu
Wei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478395

858 views

Editorial

Published on 11 Dec 2024

Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume III

in Cancer Immunity and Immunotherapy

Xuejing Zhao
Naoe Taira Nihira
Xiangpeng Dai
Zichuan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1533926

607 views

Editorial

Published on 11 Dec 2024

Editorial: Spotlighting the interaction network of hub genes, molecules, and cells in the tumor immune microenvironment (TIME) and their contribution to malignant progression

in Cancer Immunity and Immunotherapy

Jianpeng Li
Xuanbin Wang
Run Shi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1533290

397 views

Original Research

Published on 11 Dec 2024

Migrasome regulator TSPAN4 shapes the suppressive tumor immune microenvironment in pan-cancer

in Cancer Immunity and Immunotherapy

Lin-jian Wang
Ruiyan Xu
Yangyang Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419420

1,593 views

Original Research

Published on 11 Dec 2024

TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC

in Cancer Immunity and Immunotherapy

Chaopin Yang
Jinqi You
Yizhi Wang
Si Chen
Yan Tang
Hao Chen
Haoran Zhong
Ruyue Song
Hao Long
Tong Xiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499731

1,726 views

Original Research

Published on 11 Dec 2024

Mitochondria-associated programmed cell death: elucidating prognostic biomarkers, immune checkpoints, and therapeutic avenues in multiple myeloma

in Cancer Immunity and Immunotherapy

Gongzhizi Gao
Jiyu Miao
Yachun Jia
Aili He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448764

1,321 views

Original Research

Published on 10 Dec 2024

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Xin Wang
Lang Jiang
Juan Zhao
Mi Wu
Jin Xiong
Xiongwen Wu
Xiufang Weng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456209

721 views

Opinion

Published on 10 Dec 2024

Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity

in Cancer Immunity and Immunotherapy

Dianying Zhang
Jingjing Zhao
Yujing Zhang
Hongfei Jiang
Dan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490129

906 views
1 citation

Original Research

Published on 10 Dec 2024

Development and validation of a novel immune-related prognostic model and the potential metastatic mechanism in synovial sarcoma

in Cancer Immunity and Immunotherapy

Yufeng Huang
Ming Gong
Jiaming Lin
Qinglian Tang
Hongmin Chen
Jinxin Hu
Chuangzhong Deng
Anfei Huang
Huixiong Feng
Guohui Song

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448464

855 views

Original Research

Published on 10 Dec 2024

AMBRA1 drives gastric cancer progression through regulation of tumor plasticity

in Cancer Immunity and Immunotherapy

Liuqi Ye
Danlei Lin
Wen Zhang
Shiji Chen
Yumiao Zhen
Sara Akkouche
Xiaoxu Liang
Cheong-Meng Chong
Hai-Jing Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494364

1,214 views

Original Research

Published on 10 Dec 2024

Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab

in Cancer Immunity and Immunotherapy

Jaejun Lee
Jae-Sung Yoo
Ji Hoon Kim
Dong Yeup Lee
Keungmo Yang
Bohyun Kim
Joon-Il Choi
Jeong Won Jang
Jong Young Choi
Seung Kew Yoon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1506355

983 views

Navigation group

Articles

Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy

Bibliometric analysis and visualization of the research on the relationship between RNA methylation and immune cell infiltration in tumors

Cytokine screening identifies TNF to potentially enhance immunogenicity of pediatric sarcomas

Advances in biomarkers for immunotherapy in small-cell lung cancer

Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses

SOX13 as a potential prognostic biomarker linked to immune infiltration and ferroptosis inhibits the proliferation, migration, and metastasis of thyroid cancer cells

Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume III

Editorial: Spotlighting the interaction network of hub genes, molecules, and cells in the tumor immune microenvironment (TIME) and their contribution to malignant progression

Migrasome regulator TSPAN4 shapes the suppressive tumor immune microenvironment in pan-cancer

TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC

Mitochondria-associated programmed cell death: elucidating prognostic biomarkers, immune checkpoints, and therapeutic avenues in multiple myeloma

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma

Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity

Development and validation of a novel immune-related prognostic model and the potential metastatic mechanism in synovial sarcoma

AMBRA1 drives gastric cancer progression through regulation of tumor plasticity

Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab